Hypochondria can, in extreme cases, leave people unable to hold down a job or make it impossible for them to leave the house, ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into ...

Since this observation was published in the early 2000s, ketamine clinics, where the drug is administered intravenously to treat depression, have been established in cities nationwide ... Moreover, ...

Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.

Genetic testing examines a person’s DNA to identify specific genes or variants that influence how they may respond to ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Twelve months after two 16 mg doses of the drug, called CYB003, seven patients saw their scores improve on the ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

A Swedish startup has developed a high-tech headset that fights depression. Here's how it works.

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...